Remission induction with Poly IC in patients with acute lymphoblastic leukaemia (preliminary results).
D000276:Adjuvants, Immunologic; D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D003597:Cytosine Nucleotides / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D009705:Nucleosides / Q000494:pharmacology / Q000627:therapeutic use; D011119:Polynucleotides / Q000494:pharmacology / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D003597:Cytosine Nucleotides; D009705:Nucleosides; D011119:Polynucleotides